Page last updated: 2024-08-22

fluorescein and Pulmonary Embolism

fluorescein has been researched along with Pulmonary Embolism in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, TF; Chou, CY; Chou, DS; Hsiao, G; Lin, CH; Lin, KH; Shen, MY; Sheu, JR; Tzu, NH1
AKER, UT; CARTER, LP; PARKER, BM1
Chao, SH; Huang, TF; Sheu, JR; Yen, MH1
Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC1
Hung, WC; Lee, YM; Sheu, JR; Wu, CH; Yen, MH1
Hsiao, G; Lee, YM; Sheu, JR; Yen, MH1

Other Studies

6 other study(ies) available for fluorescein and Pulmonary Embolism

ArticleYear
Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo.
    European journal of pharmacology, 2003, Apr-04, Volume: 465, Issue:3

    Topics: Adenine; Animals; Bleeding Time; Blood Platelets; Electron Spin Resonance Spectroscopy; Fibrinolytic Agents; Fluorescein; Free Radical Scavengers; Free Radicals; Humans; In Vitro Techniques; Infusions, Intravenous; Kinetin; Mesenteric Vascular Occlusion; Mice; Platelet Activation; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Thrombosis; Venules

2003
The use of fluorescein dye as a marker of thrombotic emboli in experimental pulmonary embolism.
    The Journal of laboratory and clinical medicine, 1962, Volume: 60

    Topics: Biomarkers; Embolism; Fluorescein; Fluoresceins; Humans; Pulmonary Embolism; Thrombosis

1962
In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
    Thrombosis and haemostasis, 1994, Volume: 72, Issue:4

    Topics: Acute Disease; Adenosine Diphosphate; Alprostadil; Amino Acid Sequence; Animals; Blood Pressure; Endothelium, Vascular; Fluorescein; Fluoresceins; Heparin; Indomethacin; Male; Mesentery; Mice; Mice, Inbred ICR; Molecular Sequence Data; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pulmonary Embolism; Thrombosis; Venules

1994
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Disease Models, Animal; Enzyme Activation; Fibrinolytic Agents; Fluorescein; Fluoresceins; Guanylate Cyclase; Indazoles; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Serum Globulins; Solubility; Thrombosis

1997
Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments.
    British journal of haematology, 2000, Volume: 110, Issue:1

    Topics: Adenosine Diphosphate; Alkaloids; Animals; Aspirin; Bleeding Time; Blood Pressure; Drugs, Chinese Herbal; Fluorescein; Indole Alkaloids; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Quinazolines; Rats; Rats, Sprague-Dawley

2000
Antithrombotic effect of PMC, a potent alpha-tocopherol analogue on platelet plug formation in vivo.
    British journal of haematology, 2002, Volume: 117, Issue:3

    Topics: Adenosine Diphosphate; Animals; Antioxidants; Aspirin; Bleeding Time; Blood Pressure; Chromans; Fluorescein; Mesenteric Arteries; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Thrombosis

2002